A cost-effectiveness analysis of anthelminthic intervention for community control of soil-transmitted helminth infection: levamisole and Ascaris lumbricoides.
A study to compare effects of mass, targeted, and selective chemotherapy with levamisole as an intervention for the control of Ascaris lumbricoides was carried out in 3 communities in rural Oyo State, Nigeria. Selective treatment was applied in 1 village by treating the most heavily infected 20% of the inhabitants, targeted treatment in the second village involved children aged 2-15 yr, whereas mass treatment was offered to all inhabitants in the third village, excluding infants under 1 yr and pregnant women. Intensity (eggs per gram,) of A. lumbricoides infection was determined immediately before and 3 mo after the period of intervention as a means of assessing the relative efficacy of the treatment regimes. During the field study, information on resource use was also collected for a retrospective cost analysis of the 3 strategies Resources used included manpower, materials, drugs, and transport. The results of the parasitological evaluation on the effect of treatment on egg intensity were then combined with the cost analysis to provide an overall measure of the cost-effectiveness of mass, targeted, and selective interventions. The results were expressed in terms of the cost per 1,000 egg reduction in intensity and the cost per person treated. The results showed the mass and targeted approach to be considerably more cost effective than the selective approach.
Holland
C V
CV
Department of Zoology, Trinity College, Dublin, Ireland.
O'Shea
E
E
Asaolu
S O
SO
Turley
O
O
Crompton
D W
DW
D000293:Adolescent; D000328:Adult; D000818:Animals; D000969:Antinematodal Agents / Q000191:economics / Q000627:therapeutic use*; D001196:Ascariasis / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control*; D017164:Ascaris lumbricoides / Q000187:drug effects / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D005243:Feces / Q000469:parasitology; D017048:Health Care Costs; D006801:Humans; D007223:Infant; D007978:Levamisole / Q000191:economics / Q000627:therapeutic use*; D009549:Nigeria; D010270:Parasite Egg Count; D010349:Patient Compliance; D012189:Retrospective Studies
D000969:Antinematodal Agents; D007978:Levamisole